On September 3, 2020 Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, reported that management will participate in the following virtual investor conferences in September (Press release, Bicycle Therapeutics, SEP 3, 2020, View Source [SID1234564385]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi 15th Annual BioPharma Virtual Conference on Thursday, September 10, 2020
Goldman Sachs 10th Annual Biotech Symposium on Friday, September 11, 2020
H.C. Wainwright 22nd Annual Global Investment Conference on Monday, September 14, 2020; presentation at 1:00 p.m. ET
Cantor Global Healthcare Conference on Wednesday, September 16, 2020; presentation at 9:20 a.m. ET
Oppenheimer Fall Healthcare Life Sciences & Medtech Summit on Monday, September 21, 2020; presentation at 10:50 a.m. ET
A live webcast of each presentation will be accessible in the Investors & Media section of Bicycle’s website at www.bicycletherapeutics.com. Archived replays of the webcasts will be available for 90 days following the presentation dates.